{"type":"img","src":"//cdn.quv.kr/n0a6l00cv/up/5d57a90ea68a2_1920.png","height":"40"}
  • About
  • People
  • Acceleration Portfolio
  • Investment Portfolio
  • Projects
    • {"google":["Raleway","Mada"],"custom":["Noto Sans KR"]}
    LOGO
    ×
     
     
    섹션 설정
    {"type":"img","src":"//cdn.quv.kr/n0a6l00cv/up/5d57a90ea68a2_1920.png","height":"40"}
  • About
  • 투자 포트폴리오
  • 보육 포트폴리오
  • Notice
  • Gallery
  • 출자 및 투자문의

    • ABOUT US


    " From seeds of innovation to forests of growth "

    GENAXIS is a deep-tech focused TIPS operator that intensively nurtures 

    and invests in super-gap startups with outstanding technologies.


    We support the growth of deep-tech startips with broad market scope and strong potential.

    We seek innovative deep-tech companies that can grow together

    with our capabilities while considering both investor returns and corporate growth potential.


    As a micro venture capitalist dedicated to discovering  promising startups

    suited to the deep-tech era - the core technology era of the Fourth Industrial Revolution - 

    GENAXIS is always open to innovators.


    GENAXIS will continue contributing to the development of deep-tech industries that will lead the future of the 21st century 

    Investment

    Founder / CEO

    Mikyung Son

    • Oversees GENAXIS’s investment and acceleration strategy, focusing on connecting deep-tech and bio-based innovative companies to global markets.

    •  

    • -B.S. in Genetic Engineering, Sungkyunkwan University; M.S. in Dentistry, Seoul National University;

    • -MBA, Hult International Business School

    • -New product development and policy division TFT at Lotte R&D Center

    • -Recipient, Best Female Accelerator Award, Korea Women Venture Association (2021)

    • -Minister of Health and Welfare Award for Technology Commercialization (2023)

    • -Director, Korea Early Stage Investors Association

    •  

    Partner

    Junkeun Kim

    A partner who has supported corporate global expansion and investment since the early days of Korea’s accelerator ecosystem, with a focus on deep tech, especially bio and healthcare.

    .

    - B.S. in Pharmacy / Pharmacist
    - Pusan National University; B.S. and M.S. in Chemistry / Ph.D. coursework completed Pusan National University
    - Co-founded a global accelerator in 2014
    - Supports global business expansion into the U.S., Latin America, Asia, and the Middle East
    -  Performs portfolio sourcing and growth strategy advisory

    Investment Director

    Sungil Kim

    • An investment professional with extensive experience across deal sourcing, investment execution, and exits for early-stage and growth-stage companies.

       

    • Network based on years of bio company investment experience

    • More than 700 private unlisted investments and multiple exit experiences

    • Provides business advisory and investment strategy consulting

    • Completed bio investment professional training program

       

    Venture Partner

    Kwansun Park

    A hands-on leader who led core technology development in display and semiconductor industries and founded a technology company that reached public listing. He advises materials, parts, and equipment startups and serves as a bridge for Japan market entry.

     

    - Ph.D. in Engineering, Kyushu University, Japan
    - Current Head, Kyushu University Seoul Office
    - Current Management/Technology Advisor, APRO and Moacom Korea
    - Former Research Team Leader, Samsung Advanced Institute of Technology (Samsung Electronics and Samsung SDI)
    - Former TFT-LCD Development Team Leader, Samsung Electronics
    -  Former Founding CTO / Board Member, Samyoung S&C

     

     

    Venture Partner

    Jooyoung Kim

    A venture partner providing investment and technology advisory in global healthcare and digital therapeutics.

     

     

     

    - Pharm.D., Northeastern University
    - Global business development and investment advisory
    -  Board Member, Digital Therapeutics Alliance

    -  Mentor, MIT Hacking Medicine

    -  Global healthcare investment and technology advisory

     

    Head of Division

    Hojun Lee

    Oversees GENAXIS’s strategy and financial operations based on experience spanning global finance and industry operations.

     

     

    - B.A. and Ph.D. in Biochemistry, University of Cambridge

    -  Senior Analyst at J.P. Morgan (10 years)

    -  Experience in bio-venture IPOs and fundraising

    - CEO experience across smart aquaculture, IT, RPA, and other industries

    - Founded and operated manufacturing companies

     

    Principal

    Eunok Shin

    An investment professional who conducts startup growth strategy and investment review based on experience in corporate strategy organizations and CVC investment.

     

    - MBA candidate, Sungkyunkwan University

    - Future Growth Strategy Team, Youngone Holdings

    - CVC Investment Manager, YOH

    - Investment Review, Douzone Holdings

    - Securities Reviewer, Crowdy

     

    Principal

    Gilwoon Kim

    An execution-oriented investment professional with both startup and investment experience, supporting startups closely across the full journey from early growth to expansion.

    .

     

    - M.S. candidate in Convergence Studies, Pusan

    - National University; Investment Manager, Co-up Partners

    -  Experience as startup accelerator and startup operator

    - IT mentor, Gyeongsangnam-do Youth Mentor Group

    - GP activities in individual investment associations

     

    Fund & TIPS

    Yoonjung Yang

    Seunghee Kim

    Jiyeon Lee

    Acceleration

    Kyung Hoon Baek

     

    Seohyun Lee

     

    49개 사

     

    투자기업 수

    206억 원

     

    직접투자 금액

    44개 조합

     

    운용 조합 수

    810억 원

     

    후속 투자 유치 금액

    HISTORY

     

    Year 2025

    Fund established: KRW 1.5 billion

     

    Year 2024

    Funds established: KRW 5.5 billion

     

    Year 2023

    Funds established: KRW 5.21 billion

    Certified as a venture company

    Selected as a TIPS operator (14th cohort)

     
     

    Year 2022

    Funds established: KRW 4.08 billion

     

    Year 2021

    Funds established: KRW 3.41 billion

    Registered as a woman-owned enterprise

     

    Year 2020

    Funds established: KRW 1.3 billion

     

    Year 2019

     

    Registered as an accelerator (Registration No. 2019-54)

     

    투자 가치

    혁신성

    시장성

    진취성

    수익성

    {"google":["Raleway"],"custom":["Noto Sans KR","Nanum Gothic"]}{"google":["Raleway","Mada","Ubuntu"],"custom":["Noto Sans KR","Nanum Gothic"]}

    GENAXIS Inc.

    Company : GENAXIS Inc ｜ CEO : Mikyung Son

    Address: Room 717, Dreamplus Gangnam, 311 Gangnam-daero, Seocho-gu, Seoul, Republic of Korea

    Phone : +82-2-557-3008(Business Hours : Weekdays 09:00-18:00, Lunch 12:00-13:00)

    COPYRIGHT (C) 2019 Genaxis Inc.. All Rights reserved

    젠엑시스 주식회사 ｜ 대표이사 : 손미경 ｜ 개인정보책임자 : 손미경
    소재지 : 서울특별시 서초구 강남대로 311, 717호 (드림플러스 강남)

    전화 : 02-557-3008

    (상담시간 : 평일 09:00 ~ 18:00, 점심시간 : 12:00 ~ 13:00)

    COPYRIGHT (C) 2019 Genaxis Inc.. All Rights reserved

    {"google":[],"custom":["Noto Sans KR"]}